E3 PreliminaryPreliminaryPEM unclearObservationalPeer-reviewedMachine draft
Anti-neuronal antibody levels in chronic fatigue syndrome patients with neurologic abnormalities.
Buchwald, D, Wener, M H, Komaroff, A L · Arthritis and rheumatism · 1991 · DOI
Quick Summary
This study looked at whether people with ME/CFS who have neurological symptoms (like problems with thinking or nerve function) have unusual antibodies in their blood that attack nerve cells. Researchers tested blood samples from ME/CFS patients and compared antibody levels between those with and without neurological problems. The goal was to understand whether immune system misdirection might be causing some of the neurological symptoms patients experience.
Why It Matters
This research was pioneering in investigating whether immune-mediated neuronal damage contributes to ME/CFS symptoms. Understanding potential autoimmune mechanisms could eventually lead to better diagnostic tools and targeted treatments for patients experiencing neurological complications.
Observed Findings
- Anti-neuronal antibodies were detected in ME/CFS patients with neurologic abnormalities
- Antibody levels differed between ME/CFS patients with and without neurological symptoms
- Antibodies were measured in serum samples from the study population
- The prevalence pattern suggested a potential link between immune markers and neurological manifestations
Inferred Conclusions
- Anti-neuronal antibodies may be associated with neurological symptoms in some ME/CFS patients
- Autoimmune mechanisms targeting neural tissue could contribute to a subset of ME/CFS cases
- Immunological evaluation may help identify ME/CFS patients with neurological complications
Remaining Questions
- Do anti-neuronal antibodies have a causal role in neurological symptoms or are they merely markers of immune activation?
- What is the prevalence of these antibodies across diverse ME/CFS populations and in healthy controls?
- Which specific neuronal antigens are targeted and do antibody specificity correlate with symptom profiles?
- Do antibody levels change over time and do they correlate with symptom severity or treatment response?
What This Study Does Not Prove
This study does not prove that anti-neuronal antibodies cause ME/CFS or neurological symptoms—it only shows an association. The study cannot establish causation, and the presence of antibodies does not necessarily mean they are pathogenic or responsible for patient symptoms. Findings from 1991 would require replication with modern serological techniques and larger cohorts.
Tags
Biomarker:Autoantibodies
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.1002/art.1780341123
- PMID
- 1953828
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →